The prevalence of faecal and double incontinence.

Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut (2002) 2.41

Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct (2005) 2.04

Sacral nerve stimulation in the treatment of severe faecal incontinence: long-term clinical, manometric and quality of life results. Tech Coloproctol (2013) 1.05

Fecal incontinence: a review. Dig Dis Sci (2007) 0.95

Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence. Int J Colorectal Dis (2011) 0.90

Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods. Tech Coloproctol (2007) 0.88

Investigating and treating fecal incontinence: when and how. Can J Gastroenterol (2009) 0.86

Can the outcome of pelvic-floor rehabilitation in patients with fecal incontinence be predicted? Int J Colorectal Dis (2008) 0.83

Factors contributing to fecal incontinence in older people and outcome of routine management in home, hospital and nursing home settings. Clin Interv Aging (2007) 0.82

A randomized physiotherapy trial in patients with fecal incontinence: design of the PhysioFIT-study. BMC Public Health (2007) 0.82

Male faecal incontinence presents as two separate entities with implications for management. Int J Colorectal Dis (2011) 0.80

Author overestimated need in community population with faecal incontinence. BMJ (1998) 0.80

Laparoscopic Burch colposuspension and overlapping sphincteroplasty for double incontinence. JSLS (2001) 0.75

Junior doctors. The new deal. The negotiating perspective. BMJ (1991) 0.75

Trends and current issues in adult fecal incontinence (FI): Towards enhancing the quality of life for FI patients. Environ Health Prev Med (2003) 0.75

Faecal incontinence and health related quality of life in inflammatory bowel disease patients: Findings from a tertiary care center in South Asia. World J Gastrointest Pharmacol Ther (2016) 0.75

Terminal cancer care and patients' preference for place of death: a prospective study. BMJ (1990) 7.72

Prevalence of urinary incontinence. Br Med J (1980) 7.11

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17

The trouble with ethics committees. J R Coll Physicians Lond (1994) 5.07

Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85

Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ (1992) 4.53

Accuracy of diagnosis on death certificates compared with that in hospital records. Br J Prev Soc Med (1967) 4.17

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78

Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25

Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J (1979) 2.98

Population-based distributions of haemostatic variables. Br Med Bull (1977) 2.83

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74

Multicentre trial of physiotherapy in the management of sciatic symptoms. Lancet (1981) 2.59

Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer (1981) 2.53

Fetal and infant growth and cardiovascular risk factors in women. BMJ (1995) 2.52

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) (1992) 2.49

Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39

Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22

Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14

Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). J Thromb Haemost (2006) 2.11

Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ (1991) 2.02

Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. Br J Haematol (1995) 1.91

Haemostatic variables associated with diabetes and its complications. Br Med J (1979) 1.90

Ischaemic heart disease mortality risks for smokers and non-smokers. J Epidemiol Community Health (1979) 1.85

Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85

Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84

Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther (1996) 1.84

Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ (1999) 1.76

Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67

Relationship of air temperature to various chemical, haematological, and haemostatic variables. J Clin Pathol (1979) 1.65

Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial. BMJ (1988) 1.65

Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J (1978) 1.63

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry (1999) 1.63

Epidemiological and clinical picture of Addison's disease. Lancet (1968) 1.63

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J (1980) 1.61

The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry (1999) 1.60

Helicobacter pylori-related gastritis and gastric ulcer. A continuum of progressive epithelial degeneration. Am J Clin Pathol (1992) 1.59

Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet (1977) 1.58

Factor VII in an industrial population. Br J Haematol (1974) 1.55

Antithrombotic agents in coronary artery disease. Chest (2001) 1.53

Observer variability in recording the peripheral pulses. Br Heart J (1968) 1.51

Haemostatic changes that constitute the hypercoagulable state. Lancet (1991) 1.47

Our lives and hard times. Lancet (1975) 1.47

Occupational therapists' perceptions of evidence-based practice. Am J Occup Ther (1999) 1.47

Management of urinary incontinence in patients with multiple sclerosis. J R Coll Gen Pract (1981) 1.45

Characterization of the structure and properties of authentic and counterfeit polypropylene surgical meshes. Hernia (2006) 1.44

Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease. Arch Intern Med (2000) 1.44

Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) (1985) 1.42

Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery. Stroke (1989) 1.41

The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer (1998) 1.40

Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. Cancer Genet Cytogenet (1995) 1.40

Reduction of azo dyes by intestinal anaerobes. Appl Environ Microbiol (1978) 1.40

Factors predisposing to ischaemic heart disease. Proc R Soc Med (1969) 1.38

Hypertriglyceridaemia and hypercoagulability. Lancet (1983) 1.34

Haemostasis in normal pregnancy. Thromb Haemost (1984) 1.33

Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) (1987) 1.30

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

Assessment of motor function in studies of chronic disability. Rheumatol Rehabil (1980) 1.27

Detection of immune response against synthetic polymers of amino acids employing the plaque-forming cell system. I. Reaction with sheep erythrocytes coated with polymer. J Immunol (1967) 1.26

Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry (2006) 1.25

Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol (1993) 1.25

Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis. Br J Prev Soc Med (1975) 1.24

An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol (1976) 1.23

Social class, smoking, and obesity. Br Med J (1978) 1.23

Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20

Psychoneurotic profiles of smokers and non-smokers. Br Med J (1980) 1.19

Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br Med J (1977) 1.18

Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis (1986) 1.17

Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatry (1990) 1.16

Benign cystic mesothelioma of the peritoneum: immunohistochemical and ultrastructural features in a child. Pediatr Pathol (1988) 1.14

Community studies of the health service implications of low back pain. Spine (Phila Pa 1976) (1997) 1.10

Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coagul Fibrinolysis (1994) 1.10

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation (2000) 1.10

S100 protein and myoepithelial cells of breast. J Clin Pathol (1987) 1.09

A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost (1992) 1.08

Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. J Neurol Neurosurg Psychiatry (1997) 1.07

Mean cell volume in a working population: the effects of age, smoking, alcohol and oral contraception. Br J Haematol (1979) 1.07

Observer variability in cardiology. Proc R Soc Med (1968) 1.07

Apoptosis induced in macrophages and T blasts by the mycotoxin sporidesmin and protection by Zn2+ salts. Int J Immunopharmacol (1990) 1.05

Recent history of ischaemic heart disease and duodenal ulcer in doctors. Br Med J (1968) 1.04

The epidemiology of plasma renin. Clin Sci (Lond) (1983) 1.04

Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost (1983) 1.03

Randomised trial of community-based centre versus conventional hospital management in treatment of alcoholism. Lancet (1986) 1.03

Consideration of environmental change in performance assessments. J Environ Radioact (2005) 1.02

Publication bias in qualitative research: what becomes of qualitative research presented at conferences? J Epidemiol Community Health (2008) 1.00

Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia (1994) 0.99

Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Community Health (1989) 0.98

Pneumoperitoneum following tension pneumothorax. Report of two cases. Crit Care Med (1976) 0.98

Recent respiratory infection and the risk of myocardial infarction. Heart (2005) 0.98

Incidence of free colorectal cancer cells on the peritoneal surface. Dis Colon Rectum (1997) 0.98

A novel sulfonylurea receptor family member expressed in the embryonic Drosophila dorsal vessel and tracheal system. J Biol Chem (1999) 0.98